Correspondence previously treated with spironolactone [5,6] and could Subclinical target organ damage in reflect a confounding factor on ARR outcomes. Could primary aldosteronism: resistant to the authors clarify whether the same wash-out period (3 weeks) was applied for spironolactone users as well spironolactone therapy? or a larger wash-out period was applied in this group? Konstantinos Stavropoulos , a b Konstantinos P. Imprialos , Michael Doumas , ACKNOWLEDGEMENTS a a Vasilios G. Athyros , and Asterios Karagiannis Conflicts of interest There are no conflicts of interest. e read with great interest the study by Chen et al. REFERENCES . The study confirmed the extended target- 1. Chen ZW, Huang KC, Lee JK, Lin LC, Chen CW, Chang YY, et al. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain W organ damage in patients with primary aldoster- imaging study. JHypertens 2017; doi:10.1097/HJH.0000000000001534. onism by evaluating several echocardiographic indexes of [Epub ahead of print]. left ventricular function. However, we would like to make a 2. ESH/ESC Task Force for the Management of Arterial Hypertension. few points. 2013 Practice guidelines for the management of arterial hypertension of First, the selection criteria for the control group are not the European Society of Hypertension
Journal of Hypertension – Wolters Kluwer Health
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera